DEFB121

defensin beta 121, the group of Defensins, beta

Basic information

Region (hg38): 20:31404845-31412838

Links

ENSG00000204548NCBI:245934OMIM:616075HGNC:18101Uniprot:Q5J5C9AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the DEFB121 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the DEFB121 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
3
clinvar
3
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 3 0 0

Variants in DEFB121

This is a list of pathogenic ClinVar variants found in the DEFB121 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
20-31404938-C-T not specified Uncertain significance (Jan 26, 2022)2204659
20-31404992-C-T not specified Uncertain significance (Mar 13, 2023)2473277
20-31405070-C-T not specified Uncertain significance (Mar 20, 2023)2514336
20-31406110-C-T not specified Uncertain significance (Mar 28, 2024)3271461

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
DEFB121protein_codingprotein_codingENST00000376314 27994
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.09650.5931256430261256690.000103
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.06303836.91.030.00000156474
Missense in Polyphen98.55741.0517106
Synonymous-0.5121714.51.176.22e-7154
Loss of Function0.093011.110.9054.69e-813

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001830.000181
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.0001670.000167
Middle Eastern0.000.00
South Asian0.000.00
Other0.0004900.000489

dbNSFP

Source: dbNSFP

Function
FUNCTION: Has antibacterial activity. {ECO:0000305}.;
Pathway
Antimicrobial peptides;Innate Immune System;Immune System;Beta defensins;Defensins (Consensus)

Recessive Scores

pRec
0.0576

Intolerance Scores

loftool
0.626
rvis_EVS
-0.08
rvis_percentile_EVS
47.79

Haploinsufficiency Scores

pHI
0.0395
hipred
N
hipred_score
0.146
ghis
0.432

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.114

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumLowMedium
Primary ImmunodeficiencyMediumLowMedium
CancerMediumMediumMedium

Gene ontology

Biological process
defense response to bacterium;innate immune response
Cellular component
extracellular region
Molecular function
molecular_function;protein binding